660 related articles for article (PubMed ID: 7806579)
1. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.
Miettinen PJ; Ebner R; Lopez AR; Derynck R
J Cell Biol; 1994 Dec; 127(6 Pt 2):2021-36. PubMed ID: 7806579
[TBL] [Abstract][Full Text] [Related]
2. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
Piek E; Moustakas A; Kurisaki A; Heldin CH; ten Dijke P
J Cell Sci; 1999 Dec; 112 ( Pt 24)():4557-68. PubMed ID: 10574705
[TBL] [Abstract][Full Text] [Related]
3. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
Maeda M; Shintani Y; Wheelock MJ; Johnson KR
J Biol Chem; 2006 Jan; 281(1):59-68. PubMed ID: 16267045
[TBL] [Abstract][Full Text] [Related]
4. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
Gorska AE; Joseph H; Derynck R; Moses HL; Serra R
Cell Growth Differ; 1998 Mar; 9(3):229-38. PubMed ID: 9543389
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching.
Joseph H; Gorska AE; Sohn P; Moses HL; Serra R
Mol Biol Cell; 1999 Apr; 10(4):1221-34. PubMed ID: 10198068
[TBL] [Abstract][Full Text] [Related]
6. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
Feng XH; Derynck R
EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801
[TBL] [Abstract][Full Text] [Related]
7. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity.
Bhowmick NA; Zent R; Ghiassi M; McDonnell M; Moses HL
J Biol Chem; 2001 Dec; 276(50):46707-13. PubMed ID: 11590169
[TBL] [Abstract][Full Text] [Related]
8. A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation.
Kondo M; Cubillo E; Tobiume K; Shirakihara T; Fukuda N; Suzuki H; Shimizu K; Takehara K; Cano A; Saitoh M; Miyazono K
Cell Death Differ; 2004 Oct; 11(10):1092-101. PubMed ID: 15181457
[TBL] [Abstract][Full Text] [Related]
9. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
[TBL] [Abstract][Full Text] [Related]
10. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
Park CY; Kim DK; Sheen YY
Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.
Itoh S; Thorikay M; Kowanetz M; Moustakas A; Itoh F; Heldin CH; ten Dijke P
J Biol Chem; 2003 Feb; 278(6):3751-61. PubMed ID: 12446693
[TBL] [Abstract][Full Text] [Related]
12. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
Sokol JP; Neil JR; Schiemann BJ; Schiemann WP
Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131
[TBL] [Abstract][Full Text] [Related]
13. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
[TBL] [Abstract][Full Text] [Related]
14. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.
Bailey JP; Nieport KM; Herbst MP; Srivastava S; Serra RA; Horseman ND
Mol Endocrinol; 2004 May; 18(5):1171-84. PubMed ID: 14963111
[TBL] [Abstract][Full Text] [Related]
15. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor.
Filvaroff EH; Ebner R; Derynck R
Development; 1994 May; 120(5):1085-95. PubMed ID: 8026322
[TBL] [Abstract][Full Text] [Related]
17. Regulatory expression of genes related to metastasis by TGF-beta and activin A in B16 murine melanoma cells.
Murakami M; Suzuki M; Nishino Y; Funaba M
Mol Biol Rep; 2010 Mar; 37(3):1279-86. PubMed ID: 19288218
[TBL] [Abstract][Full Text] [Related]
18. Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition.
Lenferink AE; Magoon J; Cantin C; O'Connor-McCourt MD
Breast Cancer Res; 2004; 6(5):R514-30. PubMed ID: 15318933
[TBL] [Abstract][Full Text] [Related]
19. An emerging complexity of receptors for transforming growth factor-beta.
Derynck R; Chen RH; Ebner R; Filvaroff EH; Lawler S
Princess Takamatsu Symp; 1994; 24():264-75. PubMed ID: 8983081
[TBL] [Abstract][Full Text] [Related]
20. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart.
Mercado-Pimentel ME; Runyan RB
Cells Tissues Organs; 2007; 185(1-3):146-56. PubMed ID: 17587820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
